Acute insulin response (AIR): Review of protocols and clinical interest in islet transplantation

Diabetes and Metabolism

Volumn 32, Issue 4, 2006, Pages 295-303

  Marcelli Tourvieille, S ^a   Hubert, T ^a   Pattou, F ^a   Vantyghem, M C ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Department of Endocrinology and Metabolism ^*  (France)

Author keywords

Acute insulin response; AIR post arginine; AIR post glucose; Islet transplantation

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; GLUCOSE; INSULIN;

ALLOTRANSPLANTATION; ANALYTIC METHOD; AREA UNDER THE CURVE; AUTOTRANSPLANTATION; CALCIUM TRANSPORT; CLINICAL PROTOCOL; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE POTENTIATED ARGININE INSULIN STIMULATION TEST; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KINETICS; MEMBRANE DEPOLARIZATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; RISK BENEFIT ANALYSIS;

EID: 33748792296     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70283-5     Document Type: Review

References (50)

1. Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation 2005;79:1304-7.
2. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005;5:2037-46.
3. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes JAMA 2005;293:830-5.
4. Ryan EA, Paty BW, Senior PA, Bigam D, et al. Five-year follow-up after clinical islet transplantation Diabetes 2005;54:2060-9.
5. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004;47:943-56.
6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
7. Chaillous L, Rohmer V, Maugendre D, et al. Differential beta-cell response to glucose, glucagon, and argininee during progression to type I (insulin-dependent) diabetes mellitus. Metabolism 1996;45:306-14.
8. Robertson RP. Consequences on beta-cell function and reserve after long-term pancreas transplantation. Diabetes. 2004;53:633-44.
9. Bratanova-Tochkova TK, Cheng H, Daniel S, et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002;51(Suppl 1):S83-90.
10. Blachier F, Mourtada A, Sener A, Malaisse WJ. Stimulus-secretion coupling of argininee-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets. Endocrinology 1989;124:134-41.
11. Smith PA, Sakura H, Coles B, Gummerson N, Proks P, Ashcroft FM. Electrogenic argininee transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells. J Physiol 1997;499(Pt 3):625-35.
12. Thams P, Capito K. L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Eur J Endocrinol 1999;140:87-93.
13. Malaisse WJ, Blachier F, Mourtada A, et al. Stimulus-secretion coupling of argininee-induced insulin release. Metabolism of L-arginine and L-ornithine in pancreatic islets. Biochim Biophys Acta 1989;1013:133-43.
14. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta cell function in human subjects evidence for a hyperbolic function. Diabetes 1993;42:1663-72.
15. Bingley PJ, Colman P, Eisenbarth GS. Standardization of IVGTT to predict IDDM. Diabetes Care 1992;15:1313-16.
16. Lerner RL, Porte D Jr. Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab 1971;33:409-17.
17. Chen M, Porte D Jr. The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab 1976;42:1168-75.
18. Rayman G, Clark P, Schneider AE, Hales CN. The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia 1990;33:631-4.
19. Rowe RE, Leech NJ, Finegood DT, McCulloch DK. Retrograde versus antegrade cannulation in the intravenous glucose tolerance test. Diabetes Res Clin Pract 1994;25:131-6.
20. Smith CP, Tarn AC, Thomas JM. Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 1988;31:123-5.
21. Bardet S, Pasqual C, Maugendre D, Remy JP, Charbonnel B, Sai P. Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests. Diabetes Metab 1989;15:224-32.
22. Colman PG, Stewart V, Kean J. Comparison of two commonly used standard IVGTTs. Diabetes Care 1992;15:1053-5.
23. Larsson H, Ahren B. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 1998;41:772-7.
24. Ryan EA, Lakey JR, Paty BW. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;51:2148-57.
25. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished beta cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984;74:1318-28.
26. Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992;89:1761-6.
27. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
28. Kwan EP, Gaisano HY. Glucagon-like peptide 1 regulates sequential and compund exocytosis in pancreatic islet beta-cells. Diabetes 2005;54:2734-43.
29. Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA. Differential effects of acute and extensed infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and non diabetic humans. Diabetes Care 2003;26:791-8.
30. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002;9359:824-30.
31. Ahren B. Glucagon secretion in relation to insulin sensitivity in healthy subjects. Diabetologia. 2006;49:117-22.
32. Resnick DJ, Softness B, Murphy AR, Aranoff GS, Levine LS. Case report of an anaphylactoid reaction to argininee. Ann Allergy Asthma Immunol 2002;88:67-8.
33. Ryan EA, Lakey JR, Rajotte RV. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-9.
34. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998;47:324-30.
35. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh RE, Sutherland DE, Robertson RP. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 1992;327:220-6.
36. Secchi A, Dubernard JM, La Rocca E. Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients-a two-year follow-up. Transplantation 1991;51:625-9.
37. Teuscher AU, Seaquist ER, Robertson RP. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients. Diabetes 1994;43:593-8.
38. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes 2001;50:47-50.
39. Tobin BW, Lewis JT, Tobin BL, Rajotte RV, Finegood DT. Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs. Diabetes 1992;41:1172-81.
40. Van Suylichem PT, Strubbe JH, Houwing H, Wolters GH, van Schilfgaarde R. Insulin secretion by rat islets isografts of a defined endocrine volume after transplantation to three different sites. Diabetologia 1992;35:917-23.
41. Tobin BW, Lewis JT, Tobin BL, Finegood DT. Insulin action in previously diabetic rats receiving graded numbers of islets of Langerhans Transplantation 1995;59:1464-9.
42. Hubert T, Jany T, Marcelli-Tourvieille S, et al. Évaluation par Ia réponse insulinique aigue de la fonction des îlots greffés chez le miniporc pancréatectoinisé [abstract]. Diabetes Metab 2004;30:1S33-1S75.
43. Bell RC, Ryan EA, Finegood DT. Consequences of high dietary fructose in the islet transplanted rat with sub optimal beta-cell mass. Am J Physiol 1996;270(2Pt1):E292-8.
44. Robertson RP, Lanz KJ, Sutherland DE, Seaquist ER. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002;73:736-41.
45. Robertson RP. Islet transplantation as a treatment for diabetes: a work in progress. N Engl J Med 2004;350:694-705.
46. Ryan EA, Paty BW, Senior PA, Lakey JR, Bigam D, Shapiro AM. Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care 2005;28:343-7.
47. Secchi A, Taglietti MV, Socci C, et al. Insulin secretory patterns and blood glucose homeostasis after islet allotransplantation in IDDM patients: comparison with segmental- or whole-pancreas transplanted patients through a long term longitudinal study. J Mol Med 1999;77:133-9.
48. Oberholzer J, Triponez F, Mage R. Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 2000;69:1115-23.
49. Battezzati A, Benedini S, Caldara R, et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001;71:1560-5.
50. Hubert T, Jany T, Marcelli-Tourvieille S, et al. Acute insulin response of donors is correlated with pancreatic islet isolation outcome in the pig. Diabetologia 2005;48:2069-73.